UNSPSC 51421606: Clobetasone butyrate

This classification denotes a therapeutic glucocorticoid with the molecular formula C26H32ClFO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8U0H6XI6EO, chemically known as 21-chloro-9-fluoro-17-hydroxy-16-methylpregna-1,4-diene-3,11,20-trione 17-butyrate but more generally known as clobetasone butyrate, which bears US NIH Compound Identifier 71386. European Medicines Agency schedules Clobetasone butyrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01347MIG.

UNSPSC 51421606 Clobetasone butyrate is a Commodity code for a topical corticosteroid pharmaceutical product, but the recent state and local opportunities tagged under this code do not align with pharmaceutical procurement — they involve naloxone kits, drug deactivation systems, and pharmacy benefit program management infrastructure. The mismatch suggests the code shows little relevant recent activity for the product itself. State and local procurement under this specific commodity is not evident in the current opportunity set.

No representative recent opportunities for clobetasone butyrate procurement are present in the source. Bidders and business development professionals should verify whether state and local governments in their target jurisdictions are actively procuring this specific topical steroid through formal solicitations, as the two records present (Seminole County's naloxone procurement and Texas HHS's pharmacy initiative RFI) fall outside the product's scope and do not support a meaningful characterization of market demand or geographic concentration for this commodity code.